NFA
ACET icon

Northwest Financial Advisors’s Adicet Bio ACET Stock Holding History

Northwest Financial Advisors’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-105
Closed -$2.43K – 117
2024
Q3 		$2.43K Buy
+105
New +$2.35K ﹤0.01% 488
2024
Q1 		– Sell
-105
Closed -$3.19K – 90
2023
Q4 		$3.19K Buy
+105
New +$2.29K ﹤0.01% 465

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Northwest Financial Advisors's ACET Position: Q4 2024 in Review

Northwest Financial Advisors sold out of Adicet Bio (ACET) in Q4 2024, closing a stake of 105 shares — an estimated $2.43K sold.

Northwest Financial Advisors first reported a position in ACET in Q4 2023 and held it in 2 quarters. The position peaked at $3.19K in Q4 2023. 64 funds tracked by Wall St. Rank hold ACET as of Q4 2024.

  • Northwest Financial Advisors reported no remaining Adicet Bio position as of Q4 2024 after selling out during the quarter.
  • Northwest Financial Advisors sold 105 Adicet Bio shares in Q4 2024, an estimated $2.43K.
  • Northwest Financial Advisors first reported a position in Adicet Bio in Q4 2023 and held it in 2 quarters.
  • Northwest Financial Advisors's Adicet Bio position peaked at $3.19K in Q4 2023.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2024.

Based on Northwest Financial Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.